Hypertension Screening and Treatment Program
Public ClinicalTrials.gov record NCT00007592. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
VA HYPERTENSION SCREENING AND TREATMENT PROGRAM (PILOT STUDY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
Study identification
- NCT ID
- NCT00007592
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 1989
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jan 20, 2009
Started 1989
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vamc - Sepulveda | Sepulveda | California | — | — |
| Vamc - Washington, Dc | Washington D.C. | District of Columbia | — | — |
| Vamc - Miami | Miami | Florida | — | — |
| Vamc - Indianapolis | Indianapolis | Indiana | — | — |
| Vamc - Iowa City | Iowa City | Iowa | — | — |
| Vamc - Jackson | Jackson | Mississippi | — | — |
| Vamc - Dayton | Dayton | Ohio | — | — |
| Vamc - Philadelphia | Philadelphia | Pennsylvania | — | — |
| Vamc - Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| Vamc - Memphis | Memphis | Tennessee | — | — |
| Vamc - Richmond | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00007592, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2009 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00007592 live on ClinicalTrials.gov.